Japan Institute Signs Contract To Sell Smallpox Vaccine To U.S.
This article was originally published in PharmAsia News
Executive Summary
A Japanese institute has reached an agreement to provide the U.S. government with up to $34 million worth of smallpox vaccines over the next five years